Cardiovascular DiseasesHydroxymethylglutaryl-CoA Reductase InhibitorsFatty Acids, Omega-3Diabetes Mellitus, Type 2Risk FactorsHypoglycemic AgentsCholesterol, LDLTreatment OutcomeEndothelium, VascularBlood PressureInsurance BenefitsHealth Benefit Plans, EmployeeCost-Benefit AnalysisRandomized Controlled Trials as TopicUnited StatesTime FactorsRisk AssessmentFollow-Up StudiesClinical Trials as TopicInsurance, Pharmaceutical ServicesRetrospective StudiesProspective StudiesPatient SelectionSurvival AnalysisDouble-Blind MethodQuestionnairesCost SharingQuality of LifeSocial Security